XE7C Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cardiff Oncology Inc

Watchlist Manager

Watchlist

Price: 1.363 EUR -4.69%

Market Cap: €61m

C	Cardiff Oncology Inc SWB:XE7C	US
M	Marchex Inc F:NHM	US
H	Holcim AG XBER:HLBN	CH
S	Samsung Electronics Co Ltd LSE:SMSN	KR
A	Accuray Inc F:XEJ	US
S	Stanley Black & Decker Inc XBER:SWF	US
	Lindbergh SpA F:D8M	IT
	Saipem SpA F:SPE1	IT
	Brookfield Asset Management Inc NYSE:BAM	CA

Profitability Summary

Cardiff Oncology Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Negative Operating Margin

-8 256%

Negative 3Y Average Operating Margin

-8 825%

Operating Margin is Increasing

-10 479% > -8 256%

Negative Net Margin

-7 736%

Negative 3Y Average Net Margin

-8 194%

Net Margin is Increasing

-9 990% > -7 736%

Negative Free Cash Flow Margin

-6 403%

Negative 3Y Average Free Cash Flow Margin

-6 739%

Free Cash Flow Margin is Increasing

-8 482% > -6 403%

Negative ROE

-71%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

75%

ROIC is Increasing

-541% > 2 404%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.